PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 6 |
| 2008 | 65 |
| 2009 | 80 |
| 2010 | 82 |
| 2011 | 98 |
| 2012 | 70 |
| 2013 | 83 |
| 2014 | 126 |
| 2015 | 81 |
| 2016 | 77 |
| 2017 | 104 |
| 2018 | 114 |
| 2019 | 111 |
| 2020 | 94 |
| 2021 | 91 |
| 2022 | 77 |
| 2023 | 69 |
| 2024 | 54 |
| 2025 | 53 |
| 2026 | 37 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Mol Cancer Res"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.
- Adib E, Nassar AH, Abou Alaiwi S, Baca SC, Hanlon T, Bou Farhat E, Tang Y, Corona RI, Seo JH, El Zarif T, Fonseca MAS, Acosta AM, Losko M, Zhang Z, Hirsch MS, Gusev A, Lawrenson K, Mouw KW, Choueiri TK, Kwiatkowski DJ, Freedman ML.
- Mol Cancer Res. Author manuscript. 2026 Jun 3;24(6):504-517. doi: 10.1158/1541-7786.MCR-25-1385.
- PMCID: PMC13682644
Adib E, et al.Mol Cancer Res. Author manuscript. 2026.PMCID: PMC13682644 -
MIR17HG Expression Is Transcriptionally Regulated by PAX3::FOXO1 and MYCN and is Necessary for Oncogenic Activity in Fusion-Positive Rhabdomyosarcoma.
- Zargar S, Raut PK, Kim H, Boudjadi S, Hoffman RA, Stanton BZ, Barr FG.
- Mol Cancer Res. Author manuscript. 2026 Aug 17:10.1158/1541-7786.MCR-26-0074. doi: 10.1158/1541-7786.MCR-26-0074. Online ahead of print.
- PMCID: PMC13641197
Zargar S, et al.Mol Cancer Res. Author manuscript. 2026.PMCID: PMC13641197 -
Correction: BRAFV600E-Driven Lung Adenocarcinoma Requires Copper to Sustain Autophagic Signaling and Processing.
- Tsang T, Gu X, Davis CI, Posimo JM, Miller ZA, Brady DC.
- Mol Cancer Res. 2026 Oct 2;24(10):870. doi: 10.1158/1541-7786.MCR-26-0652.
- PMCID: PMC13631495
Tsang T, et al.Mol Cancer Res. 2026.PMCID: PMC13631495 -
ERG Orchestrates a Dedifferentiation-Senescence-Inflammation Triad in Prostate Cancer.
- Lorenzin F, Fracassi G, Vannuccini F, Ismail M, Ciani Y, Bevilacqua R, Gasperini P, Carbone FG, Cinalli S, Grist E, Devlies W, Giesen A, Van Goubergen J, Claessens F, Joniau S, Davicioni E, Barbareschi M, Rickman DS, Lunardi A, Attard G, Zoubeidi A, Demichelis F.
- Mol Cancer Res. 2026 Oct 2;24(10):821-836. doi: 10.1158/1541-7786.MCR-25-1310.
- PMCID: PMC13631506
Lorenzin F, et al.Mol Cancer Res. 2026.PMCID: PMC13631506 -
Integrative Transcriptional and Chromatin Analyses Reveal Enhancer-Mediated Regulatory Programs Driving Breast Cancer Metastasis.
- Heredia FL, Maldonado-Vazquez N, Fogle H, Wisniewska K, Whitman AA, Kelly MR, Spanheimer PM, Carey LA, Franco HL.
- Mol Cancer Res. Author manuscript. 2026 Aug 5:10.1158/1541-7786.MCR-26-0065. doi: 10.1158/1541-7786.MCR-26-0065. Online ahead of print.
- PMCID: PMC13557034
Heredia FL, et al.Mol Cancer Res. Author manuscript. 2026.PMCID: PMC13557034 -
Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy-Resistant Breast Cancer.
- Pal P, Chitkara S, Sarpey GK, Vashi A, Rawat V, Alani F, Zhao H, Ata M, Qu J, Schiff R, Tonetti D, Greene GL, Frasor J, Atilla-Gokcumen GE, Coloff JL.
- Mol Cancer Res. 2026 Sep 2;24(9):784-800. doi: 10.1158/1541-7786.MCR-25-0964.
- PMCID: PMC13375114
Pal P, et al.Mol Cancer Res. 2026.PMCID: PMC13375114 -
Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.
- Sayar E, Richards HM, Gulati R, Patel RA, Hanratty B, Lee HJ, Coleman I, Mustafi P, Ding CC, Chen WS, Quigley D, Setty M, Lang JM, True LD, Kollath L, Lin DW, Luo J, Lee JK, Ha G, Yu EY, Cheng HH, Montgomery B, Corey E, Morrissey C, Schweizer MT, Nelson PS, Raychaudhuri R, Haffner MC.
- Mol Cancer Res. 2026 Sep 2;24(9):754-769. doi: 10.1158/1541-7786.MCR-26-0052.
- PMCID: PMC13356882
Sayar E, et al.Mol Cancer Res. 2026.PMCID: PMC13356882 -
Archetype Analysis of Lung Adenocarcinoma Premalignancy Links Heterogeneity in Premalignant Lesions to Diverging Features of Invasive Disease.
- Anderson KE, Tran LM, Krysan K, Kefella Y, Yu L, Fishbein GA, Rodriguez EF, Shabihkhani M, Stefanko DP, Green E, Liu G, Liu H, Zhang S, Kane E, Mehrad M, Spira AE, Dubinett SM, Burks EJ, Mazzilli SA, Lenburg ME, Beane JE.
- Mol Cancer Res. 2026 Sep 2;24(9):737-753. doi: 10.1158/1541-7786.MCR-25-1093.
- PMCID: PMC13455826
Anderson KE, et al.Mol Cancer Res. 2026.PMCID: PMC13455826 -
3beta-HSD1-mediated steroid back-conversion maintains androgen signaling in prostate cancer.
- Bitaraf M, Alyamani M, Fotouhi N, Shi J, Zhu Z, Chung YM, Freedman J, George DJ, Sharifi N.
- Mol Cancer Res. Author manuscript. 2026 Jul 28:10.1158/1541-7786.MCR-26-0243. doi: 10.1158/1541-7786.MCR-26-0243. Online ahead of print.
- PMCID: PMC13458341
Bitaraf M, et al.Mol Cancer Res. Author manuscript. 2026.PMCID: PMC13458341 -
E3 Ubiquitin Ligase ITCH Enhances P53 Ubiquitination-Dependent Degradation and Drives Osteosarcoma Tumorigenesis.
- Zeng J, Zhan H, Xiao J, Huang F, Bian W.
- Mol Cancer Res. 2026 Aug 4;24(8):637-648. doi: 10.1158/1541-7786.MCR-25-0687.
- PMCID: PMC13434300
Zeng J, et al.Mol Cancer Res. 2026.PMCID: PMC13434300